Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danielle Roman

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Japanese Journal of Ophthalmology|April 1, 2009
Antiglaucoma drug GLC756 and its effect on cellular cAMP and tumor necrosis factor alpha release in vitro of activated human monocytic leukemia cellsUlrich W Laengle, Rudolf Markstein, Cecile Cazaubon, et al.
Experimental Eye Research|June 9, 2005
Effects of antiglaucoma drugs timolol and GLC756, a novel dopamine D2 agonist and D1 antagonist, on endotoxin-induced-uveitis in ratsUlrich Wilhelm Laengle, Rudolf Markstein, Verena Schneider, et al.
Toxicologic Pathology|March 14, 2002
Laser technologies in toxicopathologyDanielle Roman, Brigitte Greiner, Merdol Ibrahim, et al.
Clinical & Experimental Ophthalmology|September 27, 2007
Effects of latanoprost, timolol and GLC756, a novel dopamine D(2) agonist and D(1) antagonist on LTC(4) release after rat mast cell activationUlrich W Laengle, Rudolf Markstein, Dominique Pralet, et al.
Experimental Eye Research|September 13, 2006
Effect of GLC756, a novel mixed dopamine D1 receptor antagonist and dopamine D2 receptor agonist, on TNF-alpha release in vitro from activated rat mast cellsUlrich Wilhelm Laengle, Rudolf Markstein, Dominique Pralet, et al.
Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Fur Toxikologische Pathologie|May 23, 2006
The minipig in dermatotoxicology: methods and challengesJörg Andreas Mahl, Beate E Vogel, Mireille Court, et al.
Experimental Eye Research|August 30, 2006
GLC756 decreases TNF-alpha via an alpha2 and beta2 adrenoceptor related mechanismUlrich W Laengle, Anne U Trendelenburg, Rudolf Markstein, et al.
Journal of Cardiovascular Pharmacology|November 1, 2002
Combination of low-dose valsartan and enalapril improves endothelial dysfunction and coronary reserve in Nomega-nitro-L-arginine methyl ester-treated spontaneously hypertensive ratsMarc de Gasparo, Patrick Hess, Martine Clozel, et al.
Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Fur Toxikologische Pathologie|January 6, 2004
Effects of epithelial growth factor receptor (EGFR) kinase inhibitors on genetically reconstituted mouse mammary glandsDaniel R Roth, Danielle Roman, Robert Cozens, et al.
Biochemical Pharmacology|November 6, 2003
LAV694, a new antiproliferative agent showing improved skin tolerability vs. clinical standards for the treatment of actinic keratosisJesús Medina, Valérie Picarles, Brigitte Greiner, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Japanese Journal of Ophthalmology|April 1, 2009
Antiglaucoma drug GLC756 and its effect on cellular cAMP and tumor necrosis factor alpha release in vitro of activated human monocytic leukemia cellsUlrich W Laengle, Rudolf Markstein, Cecile Cazaubon, et al.
Experimental Eye Research|June 9, 2005
Effects of antiglaucoma drugs timolol and GLC756, a novel dopamine D2 agonist and D1 antagonist, on endotoxin-induced-uveitis in ratsUlrich Wilhelm Laengle, Rudolf Markstein, Verena Schneider, et al.
Toxicologic Pathology|March 14, 2002
Laser technologies in toxicopathologyDanielle Roman, Brigitte Greiner, Merdol Ibrahim, et al.
Clinical & Experimental Ophthalmology|September 27, 2007
Effects of latanoprost, timolol and GLC756, a novel dopamine D(2) agonist and D(1) antagonist on LTC(4) release after rat mast cell activationUlrich W Laengle, Rudolf Markstein, Dominique Pralet, et al.
Experimental Eye Research|September 13, 2006
Effect of GLC756, a novel mixed dopamine D1 receptor antagonist and dopamine D2 receptor agonist, on TNF-alpha release in vitro from activated rat mast cellsUlrich Wilhelm Laengle, Rudolf Markstein, Dominique Pralet, et al.
Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Fur Toxikologische Pathologie|May 23, 2006
The minipig in dermatotoxicology: methods and challengesJörg Andreas Mahl, Beate E Vogel, Mireille Court, et al.
Experimental Eye Research|August 30, 2006
GLC756 decreases TNF-alpha via an alpha2 and beta2 adrenoceptor related mechanismUlrich W Laengle, Anne U Trendelenburg, Rudolf Markstein, et al.
Journal of Cardiovascular Pharmacology|November 1, 2002
Combination of low-dose valsartan and enalapril improves endothelial dysfunction and coronary reserve in Nomega-nitro-L-arginine methyl ester-treated spontaneously hypertensive ratsMarc de Gasparo, Patrick Hess, Martine Clozel, et al.
Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Fur Toxikologische Pathologie|January 6, 2004
Effects of epithelial growth factor receptor (EGFR) kinase inhibitors on genetically reconstituted mouse mammary glandsDaniel R Roth, Danielle Roman, Robert Cozens, et al.
Biochemical Pharmacology|November 6, 2003
LAV694, a new antiproliferative agent showing improved skin tolerability vs. clinical standards for the treatment of actinic keratosisJesús Medina, Valérie Picarles, Brigitte Greiner, et al.
Pageof 2